Dishman Pharmaceuticals and Chemicals Ltd has formed a joint venture company to manufacture active pharmaceutical ingredients (API) in Saudi Arabia with three partners and expects to complete work on the facility in 15 months time.

Pharma major Ranbaxy Laboratories Limited today said it will launch a generic version of the urinary disorder treatment, Flomax, next year.

Cancer focused Biotechnology Company Gloucester Pharmaceuticals Inc. has agreed to be acquired by New Jersey firm Celgene Corp. for approximately $640 million, with $340 million paid in cash up front.

World’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad based Concord Biotech through its subsidiary